Todos Medical announces commercial launch of PCR-based MonkeyPox testing in the US

Todos Medical Ltd. (OTCQB:TOMDF) CEO Gerald Commissiong joined Proactive’s Stephen Gunnion with the news that the company’s clinical testing laboratory Provista Diagnostics has now commercially launched its PCR-based MonkeyPox test in the US in a bid to join the battle to contain the virus.

Commissiong telling Proactive that testing has to ramp up significantly to prevent MonkeyPox from becoming endemic to the US.

Apart from lesion-based samples that require someone’s infection to become symptomatic, he said testing has to extend to saliva-based samples to identify MonkeyPox in pre-symptomatic stage.

Ā© 2022 The Latest StockMarket News and Interviews